-
Prognostic Value of the TLM3 Biomarker Panel for Early Fibrosis Development in MASLD Within the General Population
van Son, K. C., de Jong, J. C. B. C., Özsezen, S., Caspers, M. P. M., Augustijn, Q. J. J., Snabel, J., Galenkamp, H., Hamer, H. M., van Dijk, A.-M., van Koppen, A., Mak, A. L., van den Born, B.-J., Nieuwdorp, M., Drenth, J. P. H., Gluud, L. L., Tushuizen, M. E., Hanemaaijer, R., Verschuren, L. & Holleboom, A. G., 1 Jul 2025, In: Liver International. 45, 7, e70169.Research output: Contribution to journal › Article* › Academic › peer-review
-
Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD
Verschuren, L., Mak, A. L., van Koppen, A., Özsezen, S., Difrancesco, S., Caspers, M. P. M., Snabel, J., van der Meer, D., van Dijk, A.-M., Rashu, E. B., Nabilou, P., Werge, M. P., van Son, K., Kleemann, R., Kiliaan, A. J., Hazebroek, E. J., Boonstra, A., Brouwer, W. P., Doukas, M. & Gupta, S. & 7 others, , Dec 2024, In: Nature communications. 15, 1, p. 4564 4564.Research output: Contribution to journal › Article* › Academic › peer-review
-
Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)
van Son, K. C., van Dijk, A.-M., Driessen, S., Mak, A. L., Witjes, J. J., Houttu, V. A. T., Zwirs, D., Nieuwdorp, M., van den Born, B.-J. H., Fischer, J. C., Tushuizen, M. E., Drenth, J. P. H., Hamer, H. M., Beuers, U. H. W., Verheij, J. & Holleboom, A. G., 1 Oct 2024, In: Clinical chemistry and laboratory medicine. 62, 11, p. e236-e239Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
